NCT00421954View on ClinicalTrials.gov

Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

PHASE3CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2009

Conditions

Schizophreniform DisorderSchizoaffective DisorderPsychosisDepressive Disorder, MajorBipolar Disorder

Interventions

DRUG

Ziprasidone

subjects will use ziprasidone

Trial Locations (1)

10032

NYSPI, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

New York State Psychiatric Institute

OTHER